| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.6B | $25.0B | $21.6B | $12.2B | $1.9B | $5.6B | $20.8B | $18.9B |
| Cost of Revenue | — | $15.6B | $14.3B | — | — | — | $12.9B | $11.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.4B | $3.3B | $3.0B | $2.5B | $1.9B | $1.9B | $2.5B | $2.5B |
| Operating Income | $4.5B | $3.6B | $2.0B | $-4.4B | $-7.1B | $-8.9B | $3.3B | $3.3B |
| Net Income | $2.8B | $1.9B | $-0.1B | $-6.1B | $-9.5B | $-10.2B | $3.0B | $3.2B |
| EPS (Basic) | $2.10 | $1.50 | $-0.06 | $-5.16 | $-8.46 | $-13.20 | $4.34 | $4.45 |
| EPS (Diluted) | $2.02 | $1.44 | $-0.06 | $-5.16 | $-8.46 | $-13.20 | $4.32 | $4.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $51.7B | $49.1B | $49.1B | $51.7B | $53.3B | $53.6B | $45.1B | $42.4B |
| Current Assets | $4.2B | $3.4B | $5.3B | $7.5B | $10.1B | $10.6B | $2.1B | $2.2B |
| Cash & Equivalents | $1.9B | $1.2B | $2.4B | $4.0B | $8.9B | $9.5B | $0.5B | $1.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $13.1B | $11.6B | $11.5B | $10.6B | $10.4B | $8.7B | $9.1B | $9.2B |
| Stockholders' Equity | $12.3B | $9.3B | $6.9B | $7.1B | $12.1B | $20.6B | $25.4B | $24.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.2B | $5.9B | $4.3B | $-1.7B | $-4.1B | $-6.3B | $5.5B | $5.5B |
| Investing Cash Flow | $-3.3B | $-4.5B | $-2.8B | $-4.8B | $-3.5B | $-3.2B | $-5.3B | $-3.5B |
| Capital Expenditures | $3.6B | $4.6B | $3.3B | $4.9B | $3.6B | $3.6B | $5.4B | $3.7B |
| Financing Cash Flow | $-2.2B | $-2.6B | $-5.1B | $3.6B | $6.9B | $18.6B | $-0.7B | $-1.5B |